Safety of Percutaneous Cryoablation in Patients with Painful Bone and Soft Tissue Tumors: A Single Center Prospective Study (SCIRO-1502)

This single center prospective study is being conducted to evaluate the safety of the cryoablation for patients with pathologically diagnosed painful bone and soft tissue tumors. Enrollment of 10 patients is planned over the 3-year recruitment period. Patients have related local pain after receiving...

Full description

Saved in:
Bibliographic Details
Published inActa medica Okayama Vol. 70; no. 4; pp. 303 - 306
Main Authors Iguchi, Toshihiro, Sakurai, Jun, Hiraki, Takao, Gobara, Hideo, Fujiwara, Hiroyasu, Matsui, Yusuke, Masaoka, Yoshihisa, Kanazawa, Susumu
Format Journal Article
LanguageEnglish
Published Japan 01.08.2016
Subjects
Bone Neoplasms - complications
Clinical Protocols
Cryosurgery - adverse effects
Humans
Pain - etiology
Pain Management
Research Design
Soft Tissue Neoplasms - complications
Online AccessGet full text

Cover

More Information
Summary:This single center prospective study is being conducted to evaluate the safety of the cryoablation for patients with pathologically diagnosed painful bone and soft tissue tumors. Enrollment of 10 patients is planned over the 3-year recruitment period. Patients have related local pain after receiving medications or external radiation therapies will be included in this study. Cryoablation will be percutaneously performed under imaging guidance, and a temperature sensor will be used during treatment as necessary. The primary endpoint is prevalence of severe adverse events within 4 weeks after therapy. The secondary endpoint is effectiveness 4 weeks after the procedure.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0386-300X